Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial
The Journal of Allergy and Clinical Immunology: In Practice · 2026-11 · 14 (11) · 2615-2624.e4
DOI: 10.1016/j.jaip.2026.08.008 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-11. Verfasst von Noeul Kang und 32 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Asthma, Muscarinic Antagonists, Adrenal Cortex Hormones, Anti-Asthmatic Agents. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Korea Health Industry Development Institute.
Abstract (Originalsprache)
BACKGROUND: Type 2 (T2)-low asthma is often less responsive to ICS; however, optimal controller strategies for this phenotype remain inadequately defined. OBJECTIVE: To evaluate whether long-acting muscarinic antagonists (LAMA) are non-inferior to ICS in patients with T2-low mild asthma. METHODS: In this multicenter, pragmatic, randomized, open-label, crossover trial, adults with T2-low mild asthma (blood eosinophils
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Pulmonary, Allergy, and Critical Care Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
- Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
- Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
Förderung
- Korea Health Industry Development Institute
Zitieren
APA
Kang, N., Kim, E., Yun, S. C., Kwon, H. S., Song, W. J., Cho, Y. S., Ban, G. Y., Kim, M. H., Ahn, K. M., Kim, S. H., Kim, J. H., Park, S. Y., Park, H. J., Kim, S. H., Park, S. Y., Park, C. S., An, J., Kim, S., Nam, Y. H., …, & Kim, T. B. (2026). Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial. The Journal of Allergy and Clinical Immunology: In Practice, 14(11), 2615-2624.e4. https://doi.org/10.1016/j.jaip.2026.08.008
Vancouver
Kang N, Kim E, Yun SC, Kwon HS, Song WJ, Cho YS, et al. Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(11):2615-2624.e4. doi:10.1016/j.jaip.2026.08.008
BibTeX
@article{Kang2026,
author = {Kang, Noeul and Kim, Eunse and Yun, Sung-Cheol and Kwon, Hyouk-Soo and Song, Woo-Jung and Cho, You Sook and Ban, Ga-Young and Kim, Min-Hye and Ahn, Kyung-Min and Kim, Sang-Ha and Kim, Joo-Hee and Park, So-Young and Park, Hye Jung and Kim, Sang Hoon and Park, So Young and Park, Chan Sun and An, Jin and Kim, Sujeong and Nam, Young-Hee and Shim, Ji-Su and Lee, Jaechun and Moon, Ji-Yong and Kwon, Jae-Woo and Sohn, Kyoung-Hee and Kim, Sae-Hoon and Jang, An-Soo and Kang, Sung-Yoon and Lee, Sang Min and Hur, Gyu Young and Kim, Byung Keun and Yang, Min-Suk and Park, Han Ki and Kim, Tae-Bum},
title = {Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
volume = {14},
number = {11},
pages = {2615--2624.e4},
doi = {10.1016/j.jaip.2026.08.008}
}
EUVIMED